P20701 (ITAL_HUMAN) Homo sapiens (Human)
Integrin alpha-L UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
41 Experimental Structures
Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
---|---|---|---|---|---|---|
Structures of leukocyte integrin aLb2: The aI domain, the headpiece, and the pocket for the interna… |
Heteromer P05107; | 99.83 | 2×MG; 4×CA; 1×CL; 3×NAG; | |||
Structures of leukocyte integrin aLb2: The aI domain, the headpiece, and the pocket for the interna… |
Heteromer P05107; | 99.83 | 1×MG; 4×CA; 4×NAG; | |||
Structures of leukocyte integrin aLB2: The aI domain, the headpiece, and the pocket for the interna… |
Heteromer P05107; | 99.83 | 1×MG; 5×CA; 3×NAG; | |||
Crystal structure of intermediate affinity I domain of integrin LFA-1 with the Fab fragment of its … |
Heteromer | 98.33 | 1×MN; 3×SO4; | |||
crystal structure of ICAM-5 in complex with aL I domain |
Heteromer Q9UMF0; | 98.32 | 1×NAG; 1×MG; 4×NAG; 2×GOL; | |||
Crystal structure the Fab fragment of Efalizumab in complex with LFA-1 I domain, Form I |
Heteromer | 100 | ||||
Structure of Engineered Single Domain ICAM-1 D1 with High-Affinity aL Integrin I Domain of Native C… |
Heteromer P05362; | 98.88 | 1×MG; | |||
Crystal structure the Fab fragment of Efalizumab in complex with LFA-1 I domain, Form II |
Heteromer | 100 | 1×ZN; | |||
Crystal structure of alphaL I domain in complex with ICAM-1 |
Heteromer P05362; | 98.87 | 2×NAG; 2×NAG; 1×MG; | |||
Structural Basis of ICAM recognition by integrin alpahLbeta2 revealed in the complex structure of b… |
Heteromer P32942; | 98.27 | 1×MG; 2×NAG; | |||
CD11A I-DOMAIN WITH BOUND MN++ | homo-2-mer | 100 | 2×MN; 2×CL; | |||
CD11A I-DOMAIN WITH BOUND MAGNESIUM ION | homo-2-mer | 100 | 2×MN; 2×CL; | |||
CD11A I-DOMAIN WITH BOUND MAGNESIUM ION | homo-2-mer | 100 | 2×MG; 2×CL; | |||
LFA-1 I domain bound to inhibitors | homo-2-mer | 99.45 | 2×E2M; | |||
NMR SOLUTION STRUCTURE OF THE INSERTED DOMAIN OF HUMAN LEUKOCYTE FUNCTION ASSOCIATED ANTIGEN-1 | monomer | 97.87 | ||||
X-ray structure of Lfa-1 I domain collected at 273 K | monomer | 100 | 1×MG; | |||
An allosteric inhibitor of LFA-1 bound to its I-domain | monomer | 100 | 1×L08; | |||
LFA-1 I domain bound to inhibitors | monomer | 99.45 | 1×BQN; | |||
X-ray structure of lfa-1 i-domain in complex with ibe-667 at 1.8a resolution | monomer | 99.45 | 1×MG; 1×1HV; | |||
X-ray structure of Lfa-1 I domain in complex with Lovastatin collected at 273 K | monomer | 100 | 1×803; 1×MG; | |||
X-ray structure of Lfa-1 I domain in complex with BMS-68852 collected at 273 K | monomer | 100 | 1×MG; 1×BJZ; | |||
LFA-1 I domain bound to inhibitors | monomer | 99.45 | 1×BQM; | |||
X-ray structure of LFA-1 I-domain in complex with LFA878 at 2.1A resolution | monomer | 99.45 | 1×MG; 1×AB8; | |||
X-ray structure of LFA-1 I-domain in complex with LFA703 at 2.2A resolution | monomer | 99.45 | 1×MG; 1×AAY; | |||
CRYSTAL STRUCTURE ANALYSIS OF THE COMPLEX LFA-1 (CD11A) I-DOMAIN / LOVASTATIN AT 2.6 A RESOLUTION | monomer | 99.45 | 1×MG; 1×803; | |||
X-ray structure of LFA-1 I-domain bound to a 1,4-diazepane-2,5-dione inhibitor at 1.8A resolution | monomer | 99.45 | 1×MG; 1×LA1; | |||
CD11A I-DOMAIN WITHOUT BOUND CATION | monomer | 100 | ||||
Crystal structure of wild type LFA1 I domain complexed with isoflurane | monomer | 99.44 | 1×ICF; 1×GOL; | |||
Crystal structure of wild type LFA1 I domain | monomer | 99.44 | ||||
Crystal Structure of the intermediate affinity aL I domain mutant | monomer | 98.88 | 1×MG; | |||
CD11A (LFA1) I-domain complexed with 7A-[(4-cyanophenyl)methyl]-6-(3,5-dichlorophenyl)-5-oxo-2,3,5,… | monomer | 100 | 1×2O7; | |||
CD11A I-domain complexed with 6-((5S,9R)-9-(4-CYANOPHENYL)-3-(3,5-DICHLOROPHENYL)-1-METHYL-2,4-DIOX… | monomer | 100 | 1×BJZ; 1×NO3; | |||
Structure of a single-chain beta3 integrin | monomer | 99.44 | 2×MG; 4×NAG; | |||
Crystal structure of an extended b3 integrin P33 | monomer | 99.44 | 1×CA; 2×NAG; 2×GOL; | |||
Crystal structure of an extended beta3 integrin P33 | monomer | 99.44 | 1×MG; 2×NAG; | |||
Crystal structure of an extended b3 integrin L33 | monomer | 99.44 | 1×GOL; 3×NAG; 1×CA; | |||
CD11a (LFA1) I-domain complexed with BMS-587101 aka 5-[(5S, 9R)-9-(4-cyanophenyl)-3-(3,5-dichloroph… | monomer | 100 | 1×2IC; | |||
Crystal structure of high affinity alphaL I domain with ligand mimetic crystal contact | monomer | 98.84 | 1×MN; | |||
Crystal structure of high affinity alphaL I domain in the absence of ligand or metal | monomer | 98.84 | ||||
Solution structure of integrin Alpha L | monomer | 98.28 | ||||
The Integrin Alpha L Transmembrane Domain in Bicelles: Structure and Interaction with Integrin Beta… | monomer | 100 | ||||
8 SWISS-MODEL models
Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
5e6u.1.A | monomer | 0.85 | 1×MG; 2×CA; | 99.60 | ||
7p2d.1.A | monomer | 0.67 | 37.33 | |||
5es4.1.A | monomer | 0.62 | 1×MG; | 33.72 | ||
8t2v.1.A | monomer | 0.60 | 23.57 | |||
8zjf.1.B | monomer | 0.59 | 26.60 | |||
7usl.1.A | monomer | 0.54 | 1×CA; | 33.40 | ||
4cak.1.A | monomer | 0.51 | 22.60 | |||
6avu.1.A | monomer | 0.50 | 23.11 | |||
17 SWISS-MODEL models built on isoform sequence
Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|---|
Isoform 2 | 5e6u.1.A | monomer | 0.85 | 1×MG; 2×CA; | 99.60 | ||
Isoform 2 | 7p2d.1.A | monomer | 0.68 | 37.33 | |||
Isoform 2 | 5es4.1.A | monomer | 0.62 | 1×MG; | 33.65 | ||
Isoform 2 | 8zjf.1.B | monomer | 0.59 | 26.63 | |||
Isoform 2 | 8t2v.1.A | monomer | 0.53 | 23.15 | |||
Isoform 2 | 7nxd.1.A | monomer | 0.53 | 24.01 | |||
Isoform 3 | 5e6u.1.A | monomer | 0.75 | 2×CA; | 98.34 | ||
Isoform 3 | 7p2d.1.A | monomer | 0.62 | 37.63 | |||
Isoform 3 | 7p2d.1.A | monomer | 0.60 | 39.20 | |||
Isoform 3 | 5es4.1.A | monomer | 0.60 | 33.65 | |||
Isoform 3 | 8zjf.1.B | monomer | 0.57 | 26.63 | |||
Isoform 3 | 8t2v.1.A | monomer | 0.55 | 22.72 | |||
Isoform 3 | 7usl.1.A | monomer | 0.55 | 1×CA; | 33.06 | ||
Isoform 3 | 6avu.1.A | monomer | 0.53 | 22.32 | |||
Isoform 3 | 6avr.1.A | monomer | 0.52 | 22.32 | |||
Isoform 3 | 6avq.1.A | monomer | 0.52 | 22.32 | |||
Isoform 3 | 7nxd.1.A | monomer | 0.52 | 23.98 | |||